论文部分内容阅读
美络宁(药物批号:粤卫药准字第616021号)为一种促神经细胞修复和再生的药物,具有保护细胞膜结构和血脑屏障,以及减轻毒性代谢物质对神经细胞的损害作用。我们于1999年3月至1999年12月,采用随机抽样,按统一标准对68例急性脑血管病患者进行了临床疗效的研究,兹报告如下。 资料和方法 1 一般情况 本组68例急性脑血管病患者,分为治疗组36例,对照组32例。全部病例均按1995年中华医学会第四届全国脑血管病学术
The United States Ning Ning (drug batch number: Yue Wei Yao Zhunzi No. 616021) is a kind of nerve cell repair and regeneration of drugs, with the protection of cell membrane structure and the blood-brain barrier, and reduce the toxic effects of toxic substances on nerve cells. From March 1999 to December 1999, we conducted a randomized study on the clinical efficacy of 68 patients with acute cerebrovascular disease according to uniform standards. We hereby report the following. Materials and Methods 1 General 68 patients with acute cerebrovascular disease in this group, divided into treatment group 36 cases, control group 32 cases. All cases were according to the Fourth National Cerebrovascular Disease Academic of Chinese Medical Association in 1995